DONALD E. BOBO JR - 06 Feb 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP,Strategy/Corp Development
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 06 Feb 2023
Net transactions value: -$306,346
Form type: 4
Filing time: 06 Feb 2023, 19:47:19 UTC
Previous filing: 09 Jan 2023
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$236,698	+6,725	+11%	$35.20	69,286	06 Feb 2023	Direct	F1
transaction	EW	Common Stock	Sale	$543,044	-6,725	-9.7%	$80.75	62,561	06 Feb 2023	Direct	F1
holding	EW	Common Stock						38,267	06 Feb 2023	401(k)
holding	EW	Common Stock						117,320	06 Feb 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-6,725	-33%	$0.000000	13,450	06 Feb 2023	Common Stock	6,725	$35.20	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.